Evaluation of pain intensity of the masticatory muscles after occlusal appliance and combined therapy

• Main Authors: Tainá Queiroz dos Santos, Giancarlo de la Torre Canales, Celia Marisa Rizzatti-Barbosa, Victor Ricardo Manuel Muñoz-Lora
• Format: Article
• Language: English
• Published: Universidade Estadual de Campinas 2020-10-01
• Series: Brazilian Journal of Oral Sciences
• Subjects: Facial pain; Myofascial pain syndromes; Occlusal splints
• Online Access: https://periodicos.sbu.unicamp.br/ojs/index.php/bjos/article/view/8660119

Masticatory muscle pain (MMP) is a common type of orofacial pain. Occlusal appliance (OA) is contemplated as a first-line conservative approach for chronic MMP, however, integrated biopsychosocial approaches such as counseling and self-care therapies (CSG) are also considered essential. AIM: This pilot study aimed to compare the use of a combined therapy (GSG + OA) and solely OA treatment on pain intensity related to chronic MMP over a 6-month follow-up. METHODS: For this, 20 patients diagnosed with chronic MMP using the Diagnostic criteria for temporomandibular disorders (DC/TMD) were divided into 2 groups (n=10) and treated with OA or combined therapy (CoT; OA + CSG). Electromyographic muscle activity (EMG), visual analogue scale (VAS) and pressure pain threshold (PPT) were recorded at baseline, 1, 3 and 6 months after treatment. Data was collected and statistical analysis were applied at a significance level of 5%. RESULTS: Results showed no significant differences at baseline among groups for any assessment. VAS showed that both treatments decreased subjective pain in volunteers over time, but no significant differences among both groups were observed at any evaluation time. For electromyography, CoT and OA presented no significant differences throughout the experiment neither on relaxed muscle position or maximum volunteer contraction. Finally, a significantly higher PPT for CoT was found for all muscles at the last assessment point (p<0.05). CONCLUSION: These findings suggest that both treatments are effective for the reduction of pain perception (VAS) in patients with chronic MMP. However, the addition of CSG to an OA therapy may be more beneficial for the improvement of tenderness on the same patients, at least in a long-term basis (> 3 months). Notwithstanding, a larger study should be performed to substantiate these findings.